Surrozen Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0	12.5	0	0	0
Gross Profit	0	12.5	0	0	0
Selling, General & Admin	15.8	19.83	14.21	7.12	5.5
Research & Development	27.23	37.01	40.18	25.68	19.6
Other Operating Expenses	2.75	0	0	0	0
Operating Expenses	45.78	56.84	54.39	32.81	25.11
Operating Income	-45.78	-44.34	-54.39	-32.81	-25.11
Other Expense / Income	-2.74	-8.34	0.26	-0.09	-0.74
Pretax Income	-43.04	-36	-54.65	-32.72	-24.36
Net Income	-43.04	-36	-54.65	-32.72	-24.36
Shares Outstanding (Basic)	2	2	2	1	0
Shares Outstanding (Diluted)	2	2	2	1	0
Shares Change	-12.79%	40.59%	54.57%	170.73%	-
EPS (Basic)	-21.33	-15.56	-33.15	-30.75	-61.95
EPS (Diluted)	-21.33	-15.56	-33.15	-30.75	-61.95
Free Cash Flow	-40.76	-44.87	-50.08	-29.97	-22.62
Free Cash Flow Per Share	-20.20	-19.39	-30.43	-28.15	-57.51
Gross Margin	-	100.00%	-	-	-
Operating Margin	-	-354.71%	-	-	-
Profit Margin	-	-288.03%	-	-	-
Free Cash Flow Margin	-	-358.98%	-	-	-
EBITDA	-39.86	-32.74	-51.35	-29.79	-21.42
EBITDA Margin	-	-261.88%	-	-	-
Depreciation & Amortization	3.18	3.27	3.3	2.93	2.94
EBIT	-43.04	-36	-54.65	-32.72	-24.36
EBIT Margin	-	-288.03%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).